Coherus BioSciences Statistics

Total Valuation

CHRS has a market cap or net worth of $175.12 million. The enterprise value is $347.31 million.

Market Cap	175.12M
Enterprise Value	347.31M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

CHRS has 115.21 million shares outstanding. The number of shares has increased by 32.62% in one year.

Current Share Class	115.21M
Shares Outstanding	115.21M
Shares Change (YoY)	+32.62%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	1.32%
Owned by Institutions (%)	60.63%
Float	103.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.57
Forward PS	0.65
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.25

Current Ratio	1.25
Quick Ratio	1.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-14.03%
Return on Capital (ROIC)	-28.99%
Revenue Per Employee	$994,575
Profits Per Employee	-$1,471
Employee Count	306
Asset Turnover	0.56
Inventory Turnover	2.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.30% in the last 52 weeks. The beta is 0.86, so CHRS's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-28.30%
50-Day Moving Average	1.10
200-Day Moving Average	1.56
Relative Strength Index (RSI)	55.94
Average Volume (20 Days)	10,060,141

Short Selling Information

The latest short interest is 30.72 million, so 26.66% of the outstanding shares have been sold short.

Short Interest	30.72M
Short Previous Month	33.04M
Short % of Shares Out	26.66%
Short % of Float	29.74%
Short Ratio (days to cover)	8.43

Income Statement

In the last 12 months, CHRS had revenue of $304.34 million and -$450,000 in losses. Loss per share was -$0.00.

Revenue	304.34M
Gross Profit	136.08M
Operating Income	-122.23M
Pretax Income	-29.72M
Net Income	-450,000
EBITDA	-116.92M
EBIT	-122.23M
Loss Per Share	-$0.00

Full Income Statement

Balance Sheet

The company has $97.69 million in cash and $269.88 million in debt, giving a net cash position of -$172.19 million or -$1.49 per share.

Cash & Cash Equivalents	97.69M
Total Debt	269.88M
Net Cash	-172.19M
Net Cash Per Share	-$1.49
Equity (Book Value)	-87.97M
Book Value Per Share	-0.76
Working Capital	73.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.99 million and capital expenditures -$286,000, giving a free cash flow of -$62.27 million.

Operating Cash Flow	-61.99M
Capital Expenditures	-286,000
Free Cash Flow	-62.27M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross margin is 44.71%, with operating and profit margins of -40.16% and -0.15%.

Gross Margin	44.71%
Operating Margin	-40.16%
Pretax Margin	-0.15%
Profit Margin	-0.15%
EBITDA Margin	-38.42%
EBIT Margin	-40.16%
FCF Margin	n/a

Dividends & Yields

CHRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.62%
Shareholder Yield	-32.62%
Earnings Yield	-0.26%
FCF Yield	-35.56%

Analyst Forecast

The average price target for CHRS is $5.38, which is 253.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.38
Price Target Difference	253.95%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	7.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHRS has an Altman Z-Score of -3.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.94
Piotroski F-Score	2